DelveInsight's Diabetes pipeline report depicts a robust space with 200+ active players working to develop 200+ pipeline ...

MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 ...

Researchers at MIT say they designed a reservoir that releases glucagon when blood sugar levels get too low in people with diabetes.

The new implant contains a reservoir of glucagon that sits beneath the skin and can be activated in an emergency, with no need for injections. For individuals with Type 1 diabetes, the risk of ...

Hypoglycemia – a condition in which low blood glucose levels can cause you to feel dizzy, weak, and shaky – can catch you by ...

An in-depth overview of how skipping meals or following intermittent fasting impacts metabolism, hormones, appetite, and long-term health.

For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels become extremely low, it creates a life-threatening situation for which the ...

For individuals with type 1 diabetes – an autoimmune condition – maintaining stable blood sugar is a constant challenge.

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

MIT engineers developed an implantable reservoir that can remain under the skin and be triggered to release glucagon when people with diabetes are in danger of becoming hypoglycemic.  ...

Hormones can be helpful heroes, supporting the immune system and a healthy sleep-wake schedule. But they can also be culprits ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.